MedPath

COPAXONE

COPAXONE

Discontinued
DIN Number

02233014

Drug Class

Human

Market Date

Oct 14, 1997

Company
HC

梯瓦制药

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02233014
AIG Number0132525001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L03AX13 GLATIRAMER ACETATE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification92:20.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

GLATIRAMER ACETATEActive
Strength: 20 MG / VIAL
Monograph: GLATIRAMER ACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.